LSX Investival Showcase
Returning for its fifth year, LSX’s Investival Showcase directly connects life science corporates to global capital and partners – in 2020, delivered virtually!
An international showcase of early, growth stage and public life science and health technology companies, Investival Showcase provides an unrivalled opportunity to pitch, profile and connect with investors and partners brought together during the biggest fortnight in European life sciences investment. The company showcases will highlight and promote the most exciting and innovative biotech, medtech, health technology and consumer health companies across Europe and beyond.
The online experience features everything from the physical event and more! Hear from, connect, network and schedule 1:1 video meetings with global investors, corporates and strategic partners.
Investival Showcase continues its exclusive partnership with global investment bank Jefferies, running the days before the Jefferies London Healthcare Conference.
- Cancer Advances, Inc. Announces Issuance of New U.S. Patent
- Cancer Advances, Inc. Announces Abstract and Poster Presentation at ASCO GI – Role of an anti-gastrin vaccine (PAS) in combination with a PD-1 antibody on growth and metastasis of gastric cancer
- Cancer Advances, Inc. Announces Publication, “Gastrin Vaccine Alone and in Combination with an Immune Checkpoint Antibody Inhibits Growth and Metastases of Gastric Cancer” in Frontiers in Oncology
- Vaccination with Polyclonal Antibody Stimulator (PAS) Prevents Pancreatic Carcinogenesis in the KRAS Mouse Model
- Vaccination with Polyclonal Antibody Stimulator PAS Prevents Pancreatic Carcinogenesis in the KRAS Mouse Model